[关键词]
[摘要]
本文作者是大家熟知的代理复方丹参滴丸进入美国二期临床试验事务的律师。作者集多年的经验与感受，就中药进入美国的形式进行了分类分析，为关心我国中药制品进入美国市场的人们提供了一个较全面的参考。
[Key word]
[Abstract]
The purpose of this document is to share experiences in introducing Chinese herbal drugs to American markets. And distribution channels for herbal medicines entering US are also categorized and illuminated.
[中图分类号]
[基金项目]
